Associated Papers
Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non-Small-Cell Lung Cancer According to ALK Fusion and Mutation Status.
Bazhenova L et al.
Clinical Lung Cancer, 2025
Activated protein C resistance caused by Arg506Gln mutation in factor Va.
Greengard JS et al.
Lancet (london, England), 1994
Select a paper to view details